EyePoint Pharmaceuticals
Presence
EyePoint Pharmaceuticals is a company listed under the stock ticker EYPT (US).
Executives
View the org chart displaying its 20 main executives
Most searched biographies at EyePoint Pharmaceuticals
- Jay Duker, President and Chief Executive Officer
- Wendy DiCicco, Director
- Nancy Lurker, Executive Vice Chairman of the Board
Popular executive movements at EyePoint Pharmaceuticals
- Ramiro Ribeiro has joined the company as Chief Medical Officer (posted on March 5 2024).
- Dario Paggiarino, Senior Vice President & Chief Medical Officer, has left the company (posted on March 5 2024).
- Stuart Duty has joined the company as Director (posted on October 17 2023).
Create your alert
to follow the executive moves at EyePoint Pharmaceuticals.
Medical Equipment
EyePoint Pharmaceuticals has 984 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by EyePoint Pharmaceuticals
- Up and down the ladder: The latest comings and goings
- EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists | EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals appoints Ramiro Ribeiro as chief medical officer (NASDAQ:EYPT)
- Buy Rating Affirmed for EyePoint Pharmaceuticals Amid Strategic Leadership Changes and Promising Pipeline Outlook
- EyePoint Pharmaceuticals Welcomes New CMO Dr. Ramiro Ribeiro, Eyes Phase 3 Trials
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments | EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences | EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024 | EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer | EyePoint Pharmaceuticals
- View more press releases Close
Social media about EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- EyePoint Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jay Duker 
Call EyePoint Pharmaceuticals at +1 617...
